Opto Circuits

Opto Circuits, formally Opto Circuits (India) Limited, is an Indian medical-technology group established in Bangalore in 1991. The company developed an internationally oriented portfolio spanning primary care, acute care, and critical-care equipment. Its activities have included the design, manufacture, and marketing of products used to monitor patients, respond to cardiac emergencies, support vascular treatment, and measure physiological signals. The group’s operating model has been described as vertically integrated, combining manufacturing and specialist medical-device businesses with international distribution. Its portfolio has included cardiac and vital-sign monitors, emergency cardiac-care equipment, vascular-treatment systems, and sensor technologies. Group companies and brands identified in reference material include Criticare, Eurocor, Mediaid, AMDL, and Unetixs Vascular. These businesses cover adjacent areas such as patient monitoring, emergency care, vascular intervention, and sensing, giving Opto Circuits a broader medical-device footprint than a single-product manufacturer. Opto Circuits entered the public markets in 2000 through listings on the Bombay Stock Exchange and the National Stock Exchange of India. The company’s international reach was supported by direct and indirect sales channels, particularly across emerging and developing economies. Its products were described as having United States Food and Drug Administration listings and European CE marking, regulatory credentials that supported distribution in multiple jurisdictions. Reference material states that the group’s products were marketed in more than 150 countries. The company’s principal positioning has been that of a globally active, vertically integrated provider of medical equipment for routine monitoring and high-acuity clinical settings. Its product categories address hospitals, emergency services, clinicians, and other healthcare providers requiring vital-sign measurement, cardiac intervention, vascular treatment, and related sensing capabilities. The group was also included in Forbes magazine’s 2011 Asia’s Best Under a Billion list, reflecting recognition of its scale or business performance at that time. Publicly available reference material for this entry provides limited detail about later corporate developments, current ownership, management, active product names, and present operating status. Accordingly, those fields remain unconfirmed here.

Opto Circuits was established in Bangalore in 1991 as an Indian medical-device enterprise. From its early base in India, it developed a portfolio aimed at healthcare providers requiring patient monitoring, cardiac-care equipment, vascular technologies, and physiological sensing. Rather than concentrating on one narrow device category, the company pursued a broader medical-technology model covering primary care as well as acute and critical care applications. A significant stage in the company’s development came in 2000, when Opto Circuits became publicly listed on both the Bombay Stock Exchange and the National Stock Exchange of India. The listings provided the company with a public-market presence while it continued expanding its medical-device operations. The available reference material does not specify the terms of the listing, the original offer, or subsequent capital-raising activity. The group later assembled or operated a collection of specialist businesses associated with different parts of the healthcare-equipment market. Criticare was associated with monitoring and critical-care products, while Eurocor, Mediaid, AMDL, and Unetixs Vascular represented additional capabilities in cardiac care, vascular treatment, and sensing-related technologies. Together, these businesses supported an integrated portfolio rather than a single flagship device line. International distribution became central to the group’s identity. Opto Circuits’ products were described as carrying United States Food and Drug Administration listings and European CE marking, and as being sold through both direct and indirect channels. Reference material states that the products were marketed in more than 150 countries, with a particular presence across emerging and developing economies. This international approach positioned the company as an Indian-origin supplier serving global healthcare markets. The company’s product scope included cardiac and vital-sign monitors, emergency cardiac-care equipment, vascular-treatment systems, and sensing technologies. These categories placed Opto Circuits across several clinical workflows, from routine measurement and bedside monitoring to emergency response and vascular intervention. The available sources do not provide a detailed chronology for individual product launches, model generations, acquisitions, or changes in distribution strategy. In 2011, Opto Circuits was included in Forbes magazine’s Asia’s Best Under a Billion list. This recognition was a notable point in the company’s public profile and reflected its position among smaller publicly traded Asian businesses selected by the publication at that time. Beyond this milestone, the supplied reference material does not establish the company’s later ownership, leadership, financial condition, product status, or current operations. Those aspects require further verification.

• 2011

  Forbes Asia recognition

  [1]Opto Circuitsen.wikipedia.org

  The company was included in Forbes magazine’s Asia’s Best Under a Billion list.

• 2000

  Public-market listings

  [1]Opto Circuitsen.wikipedia.org

  Opto Circuits became publicly listed on the Bombay Stock Exchange and the National Stock Exchange of India.

• 1991

  Company established

  [1]Opto Circuitsen.wikipedia.org

  Opto Circuits was established in Bangalore, India, beginning its operations as a medical-technology company.

A vertically integrated Indian medical-technology group serving primary, acute, and critical care markets through monitoring, emergency cardiac-care, vascular-treatment, and sensing products.

• Patient monitoring

  Cardiac and vital-sign monitors

  Opto Circuits specialized in equipment for monitoring cardiac activity and vital signs. These products formed a central part of the group’s medical-device portfolio and were intended for clinical environments ranging from routine patient observation to acute and critical care. The supplied reference material does not identify specific models, technical specifications, or current availability.

• Emergency and critical care

  Emergency cardiac-care equipment

  The group’s portfolio included equipment for emergency cardiac care, placing Opto Circuits in settings where clinicians respond to urgent cardiovascular events. The category complemented its monitoring products and supported the company’s broader primary-, acute-, and critical-care positioning. No product-level launch dates or named models are established by the supplied sources.

• Vascular medical devices

  Vascular-treatment equipment

  Opto Circuits and associated group companies were involved in vascular-treatment technologies. This area broadened the business beyond monitoring and emergency care into devices or systems used in vascular clinical treatment. The available reference material does not provide enough detail to identify particular procedures, platforms, or present product status.

• Medical sensors

  Sensing technologies

  Sensing technologies were another stated area of specialization. These capabilities supported the measurement of physiological signals and complemented the group’s monitoring and critical-care products. Specific sensor types, applications, and branded product families are not identified in the supplied reference material.

1. 1Opto Circuitsen.wikipedia.org